Dashboard

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

S

Fundamental Variables

S

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

CEO

Raimon Grifols Roura / Victor Grifols Deu

Employees

24,016

Industry

-

Sector

-

Headquarters

Barcelona

Exchange

NASDAQ

Summary Stats

Market Cap

1.85B

Revenue

6.58B

Net Income

834M

EPS

$1.20

Price-to-Earnings

5.88

Price-to-Book

0.3

Debt-to-Equity

2.14

News

Analyst Ratings

Price targets projected by 3 analysts

High

$39.00

Average

$29.96

Low

$21.00

Ratings calculated by 6 analysts

Buy

4

Hold

2

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Not Available

Actual

- -

Consensus

0.24

Report Date

Year Ago

-

Year Ago Change %

-

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites